Myriad Genetics Inc (LTS:0K3W)
$ 13.635 0.293 (2.19%) Market Cap: 1.24 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 1.70 GF Score: 63/100

Myriad Genetics Inc Investor Day Transcript

Aug 11, 2022 / 02:00PM GMT
Release Date Price: $25.35
Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Good morning. Welcome to Myriad Genetics Investor Day. Really pleased for you to join us today, and we're very excited to have you and give you an update on the company and the great work that everyone's been doing. If we could just adjust the volume down, please. I'll just whisper. Anyway, great to have you all here this morning.

We are more excited than ever about the opportunity we see to advance our mission to empower healthcare providers and patients with important medical information to better detect, treat and prevent disease and make precision medicine available to all patients regardless of race, ethnicity or economic background.

The evolution of our healthcare system towards a more consumer-centric model where patients and family engagement drive outcomes is accelerating, value-based care, models that are physician-driven, and relying on coordinated care and informed patient engagement are becoming the norm throughout our healthcare system. And we see a growing interest and adoption by patients, payers and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot